Contractile Defect Caused by Mutation in MYBPC3 Revealed under Conditions Optimized for Human PSC-Cardiomyocyte Function

Summary Maximizing baseline function of human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) is essential for their effective application in models of cardiac toxicity and disease. Here, we aimed to identify factors that would promote an adequate level of function to permit robust single-cell contractility measurements in a human induced pluripotent stem cell (hiPSC) model of hypertrophic cardiomyopathy (HCM). A simple screen revealed the collaborative effects of thyroid hormone, IGF-1 and the glucocorticoid analog dexamethasone on the electrophysiology, bioenergetics, and contractile force generation of hPSC-CMs. In this optimized condition, hiPSC-CMs with mutations in MYBPC3, a gene encoding myosin-binding protein C, which, when mutated, causes HCM, showed significantly lower contractile force generation than controls. This was recapitulated by direct knockdown of MYBPC3 in control hPSC-CMs, supporting a mechanism of haploinsufficiency. Modeling this disease in vitro using human cells is an important step toward identifying therapeutic interventions for HCM.

[1]  L. Carrier,et al.  Cardiac Myosin-Binding Protein C Is Required for Complete Relaxation in Intact Myocytes , 2007, Circulation research.

[2]  V. Regitz-Zagrosek,et al.  The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands. , 2003, European heart journal.

[3]  R. Graham,et al.  Thyroid hormone action in postnatal heart development. , 2014, Stem cell research.

[4]  Irwin Klein,et al.  Hypothyroidism as a risk factor for cardiovascular disease , 2004, Endocrine.

[5]  K. McDonald,et al.  Hypertrophic Cardiomyopathy in Cardiac Myosin Binding Protein-C Knockout Mice , 2002, Circulation research.

[6]  S. Ikeda,et al.  Transcription Factor GATA4 Is Activated but Not Required for Insulin-like Growth Factor 1 (IGF1)-induced Cardiac Hypertrophy* , 2012, The Journal of Biological Chemistry.

[7]  M. Hey‐Mogensen,et al.  Sites of Superoxide and Hydrogen Peroxide Production by Muscle Mitochondria Assessed ex Vivo under Conditions Mimicking Rest and Exercise* , 2014, The Journal of Biological Chemistry.

[8]  Paul M. Rindler,et al.  The Oxygen-Rich Postnatal Environment Induces Cardiomyocyte Cell-Cycle Arrest through DNA Damage Response , 2014, Cell.

[9]  T. Wieland,et al.  β-Adrenergic receptor stimulation causes cardiac hypertrophy via a Gβγ/Erk-dependent pathway. , 2012, Cardiovascular research.

[10]  A. Mugelli,et al.  The effect of oxygen free radicals on calcium current and dihydropyridine binding sites in guinea‐pig ventricular myocytes , 1996, British journal of pharmacology.

[11]  Shiyong Wu,et al.  The Warburg effect: evolving interpretations of an established concept. , 2015, Free radical biology & medicine.

[12]  N. Laping,et al.  Development of a small-molecule serum- and glucocorticoid-regulated kinase-1 antagonist and its evaluation as a prostate cancer therapeutic. , 2008, Cancer research.

[13]  George A. Truskey,et al.  Modeling the mitochondrial cardiomyopathy of Barth syndrome with iPSC and heart-on-chip technologies , 2014, Nature Medicine.

[14]  J. Vicencio,et al.  New insights into IGF-1 signaling in the heart , 2014, Trends in Endocrinology & Metabolism.

[15]  E. Stanley,et al.  A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies , 2008, Nature Protocols.

[16]  Euan A Ashley,et al.  Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. , 2013, Cell stem cell.

[17]  Gang Wang,et al.  Modeling the mitochondrial cardiomyopathy of Barth syndrome with iPSC and heart-on-chip technologies , 2014 .

[18]  Yu-Li Wang,et al.  The regulation of traction force in relation to cell shape and focal adhesions. , 2011, Biomaterials.

[19]  L. Bertrand,et al.  Role of Akt/GSK-3beta/beta-catenin transduction pathway in the muscle anti-atrophy action of insulin-like growth factor-I in glucocorticoid-treated rats. , 2008, Endocrinology.

[20]  Milena Bellin,et al.  Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: Disease mechanisms and pharmacological rescue , 2014, Proceedings of the National Academy of Sciences.

[21]  D. Kelly,et al.  Peroxisome Proliferator–Activated Receptor γ Coactivator-1 (PGC-1) Regulatory Cascade in Cardiac Physiology and Disease , 2007 .

[22]  R. Passier,et al.  Expansion and patterning of cardiovascular progenitors derived from human pluripotent stem cells , 2015, Nature Biotechnology.

[23]  C. Mummery,et al.  PGC-1α and Reactive Oxygen Species Regulate Human Embryonic Stem Cell-Derived Cardiomyocyte Function , 2013, Stem cell reports.

[24]  Chris Denning,et al.  Aberrant α-Adrenergic Hypertrophic Response in Cardiomyocytes from Human Induced Pluripotent Cells , 2014, Stem cell reports.

[25]  K. Gharbi,et al.  Glucocorticoids promote structural and functional maturation of foetal cardiomyocytes: a role for PGC-1α , 2014, Cell Death and Differentiation.

[26]  D. Atsma,et al.  Serum supplemented culture medium masks hypertrophic phenotypes in human pluripotent stem cell derived cardiomyocytes , 2014, Journal of cellular and molecular medicine.

[27]  Florian Lang,et al.  Serum and glucocorticoid inducible kinases in the regulation of the cardiac sodium channel SCN5A. , 2003, Cardiovascular research.

[28]  C. Rücker-Martin,et al.  Human cardiomyocyte hypertrophy induced in vitro by gp130 stimulation. , 2003, Cardiovascular research.

[29]  S. Bhattacharya,et al.  Glucocorticoid receptor is required for foetal heart maturation. , 2013, Human molecular genetics.

[30]  Lei Yang,et al.  Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells , 2014, Cardiovascular research.

[31]  Sean P. Palecek,et al.  Effects of Substrate Mechanics on Contractility of Cardiomyocytes Generated from Human Pluripotent Stem Cells , 2012, International journal of cell biology.

[32]  D. Chrysis,et al.  Insulin-like growth factor-1 restores dexamethasone-induced heart growth arrest in rats: the role of the ubiquitin pathway , 2011, Hormones.

[33]  Jane Synnergren,et al.  Global transcriptional profiling reveals similarities and differences between human stem cell-derived cardiomyocyte clusters and heart tissue. , 2012, Physiological genomics.

[34]  K. Kolaja,et al.  Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells. , 2014, Cell reports.

[35]  M. Burch,et al.  Hypertrophic cardiomyopathy. , 1994, Archives of disease in childhood.

[36]  James A Thomson,et al.  High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. , 2011, American journal of physiology. Heart and circulatory physiology.

[37]  Richard P Davis,et al.  Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes Under Defined Conditions. , 2016, Methods in molecular biology.

[38]  T. Eschenhagen,et al.  β-Adrenergic stimulation and myocardial function in the failing heart , 2009, Heart Failure Reviews.

[39]  C. Proud,et al.  p90(RSK)s mediate the activation of ribosomal RNA synthesis by the hypertrophic agonist phenylephrine in adult cardiomyocytes. , 2013, Journal of molecular and cellular cardiology.

[40]  D. Guertin,et al.  Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex , 2005, Science.

[41]  R. Passier,et al.  NKX2-5eGFP/w hESCs for isolation of human cardiac progenitors and cardiomyocytes , 2011, Nature Methods.

[42]  S. Heymans,et al.  Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy. , 2013, Cardiovascular research.

[43]  Simona Casini,et al.  Immaturity of human stem-cell-derived cardiomyocytes in culture: fatal flaw or soluble problem? , 2015, Stem cells and development.

[44]  J. Magyar,et al.  Effects of endothelin-1 on calcium and potassium currents in undiseased human ventricular myocytes , 2000, Pflügers Archiv.

[45]  C. Chinopoulos,et al.  Quantitative measurement of mitochondrial membrane potential in cultured cells: calcium‐induced de‐ and hyperpolarization of neuronal mitochondria , 2012, The Journal of physiology.

[46]  M. Gautel,et al.  A newly created splice donor site in exon 25 of the MyBP-C gene is responsible for inherited hypertrophic cardiomyopathy with incomplete disease penetrance. , 2000, Circulation.

[47]  E. Bettiol,et al.  Developmental Changes in Cardiomyocytes Differentiated from Human Embryonic Stem Cells: A Molecular and Electrophysiological Approach , 2007, Stem cells.

[48]  Robert Passier,et al.  Functional maturation of human pluripotent stem cell derived cardiomyocytes in vitro--correlation between contraction force and electrophysiology. , 2015, Biomaterials.

[49]  F J Schoen,et al.  Comparison of Two Murine Models of Familial Hypertrophic Cardiomyopathy , 2001, Circulation research.

[50]  L. Sen,et al.  Acute effects of thyroid hormone on inward rectifier potassium channel currents in guinea pig ventricular myocytes. , 1996, Endocrinology.

[51]  D. Discher,et al.  Microscopic methods for measuring the elasticity of gel substrates for cell culture: microspheres, microindenters, and atomic force microscopy. , 2007, Methods in cell biology.

[52]  G. Pazour,et al.  The primary cilium coordinates early cardiogenesis and hedgehog signaling in cardiomyocyte differentiation , 2009, Journal of Cell Science.

[53]  Simona Casini,et al.  Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome , 2013, The EMBO journal.

[54]  M. Heymans,et al.  Preserved cross-bridge kinetics in human hypertrophic cardiomyopathy patients with MYBPC3 mutations , 2014, Pflügers Archiv - European Journal of Physiology.

[55]  E. Wouters,et al.  Synergistic stimulation of myogenesis by glucocorticoid and IGF-I signaling. , 2013, Journal of applied physiology.

[56]  I. Klein,et al.  Triiodothyronine-mediated myosin heavy chain gene transcription in the heart. , 2003, American journal of physiology. Heart and circulatory physiology.

[57]  Thomas Eschenhagen,et al.  Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice. , 2013, Journal of molecular and cellular cardiology.

[58]  F. Weinberger,et al.  Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice , 2012, Journal of molecular and cellular cardiology.

[59]  F. T. ten Cate,et al.  Cardiac Myosin-Binding Protein C Mutations and Hypertrophic Cardiomyopathy: Haploinsufficiency, Deranged Phosphorylation, and Cardiomyocyte Dysfunction , 2009, Circulation.

[60]  G. Ratto,et al.  Amiodarone inhibits the 3,5,3'-triiodothyronine-dependent increase of sodium/potassium adenosine triphosphatase activity and concentration in human atrial myocardial tissue. , 2004, Thyroid : official journal of the American Thyroid Association.

[61]  S. Dudley,et al.  Reactive Oxygen Species Originating From Mitochondria Regulate the Cardiac Sodium Channel , 2010, Circulation research.

[62]  C. Mummery,et al.  Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes , 2015, Cardiovascular research.

[63]  H. Ruohola-Baker,et al.  Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells. , 2014, Journal of molecular and cellular cardiology.

[64]  Hirotoshi Nakamura,et al.  Essential Role of TEA Domain Transcription Factors in the Negative Regulation of the MYH 7 Gene by Thyroid Hormone and Its Receptors , 2014, PloS one.

[65]  J. Seidman,et al.  Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice. , 2015, Journal of molecular and cellular cardiology.

[66]  M. Brand,et al.  The contributions of respiration and glycolysis to extracellular acid production. , 2015, Biochimica et biophysica acta.

[67]  Sean P. Palecek,et al.  Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells , 2009, Circulation research.

[68]  C. Stournaras,et al.  Regulation of transport across cell membranes by the serum- and glucocorticoid-inducible kinase SGK1 , 2014, Molecular membrane biology.

[69]  R. Hamanaka,et al.  Warburg Effect and Redox Balance , 2011, Science.

[70]  D. Kelly,et al.  Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease. , 2007, Circulation.